Tumor der Bauchspeicheldrüse | ICD10: C25
Sie befinden sich hier:
Studien offen zur Rekrutierung
ALPACA-Studie_AIO-PAK-0114136 KB
First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine (ALPACA)
ARMO ARTIST-196 KB
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Meta Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
CANFOUR-Studie37 KB
Open-Label-Studie, Dosiseskalation gefolgt von Dosisexpansion, Sicherheits- und Tolerierbarkeitsstudie von CAN04, einem vollständig humanisierten monoklonalem Antikörper gegen IL1RAP, bei Patienten mit soliden malignen Tumoren.
CONKO-007 Studie57 KB
CONKO-007: Randomisierte Phase-III-Studie zum Stellenwert einer Radiochemotherapie nach Induktionschemotherapie beim lokal begrenzten, inoperablen Pankreaskarzinom.
CONKO-020Assessment of the nutrial status changes over the course of disease Prognostic value of IL6 in patient with cancer cachexia
DKTK Surgery93 KB
Präzisionmedizin in der onkologischen Chirurgie: Identifizierung prädiktiver Biomarker für eine individualisierte chirurgische Behandlung gastrointestinaler Tumore.
Jannsen CASSINI144 KB
Efficacy and Safety of Rivaroxaban Prophylaxis Compared With Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism
Lilly I5B-MC-JGDPA Phase 1b (Open-Label) / Phase 2 (Randomized Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer
Morpheus WO3960859 KB
A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)
NEOLAP AIO-PAK-0113159 KB
Prospective Randomized Multicenter Phase II Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer
Neonax_AIO-PAK-0313159 KB
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer. A phase II study of the AIO Pancreatic Cancer Group.